Retinoic acid postconsolidation therapy for highrisk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation
F Peinemann, EC van Dalen, H Enk… - Cochrane Database of …, 2017 - cochranelibrary.com
Background Neuroblastoma is a rare malignant disease and mainly affects infants and very
young children. The tumours mainly develop in the adrenal medullary tissue, with an …
young children. The tumours mainly develop in the adrenal medullary tissue, with an …
Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to …
Background A phase I study was conducted to determine the maximumtolerated dose,
doselimiting toxicities (DLTs), and pharmacokinetics of fenretinide (4HPR) delivered in an …
doselimiting toxicities (DLTs), and pharmacokinetics of fenretinide (4HPR) delivered in an …
Coexistence of neuroblastoma detected on staging of Langerhans cell histiocytosis
T Shiohama, H Ochiai, T Hishiki… - Pediatrics …, 2014 - Wiley Online Library
Langerhans cell histiocytosis (LCH) is a rare proliferative disease accompanied by the
accumulation of pathological Langerhans cells, which often spreads into multisite and multi …
accumulation of pathological Langerhans cells, which often spreads into multisite and multi …
[HTML][HTML] Ganglioneuroblastoma Found on an Infant with Langerhans Cell Histiocytosis after Several Months of Chemotherapy: A Case Report
I Han, J Byun, JW Han, HY Kim - Advances in Pediatric Surgery, 2020 - aps-journal.org
In patients with Langerhans cell histiocytosis (LCH), it is possible for other malignancies to
develop. In the majority of cases, these are lymphomas and leukemia; however, in some …
develop. In the majority of cases, these are lymphomas and leukemia; however, in some …
[PDF][PDF] Langerhans cell histiocytosis and neuroblastoma: report of two cases with follow-up for over 3 years
X Ma - Int J Clin Exp Pathol, 2016 - e-century.us
Langerhans cell histiocytosis (LCH) is a clinically heterogeneous disorder characterized by
proliferation of abnormal bone marrow derived dendritic cells. Neuroblastoma (NB) is …
proliferation of abnormal bone marrow derived dendritic cells. Neuroblastoma (NB) is …
[HTML][HTML] Přehled léčby histiocytózy z Langerhansových buněk u osob dospělého věku
Z Adam, M Krejčí, L Pour, P Szturz… - Vnitřní …, 2010 - casopisvnitrnilekarstvi.cz
Léčba histiocytózy z Langerhansových buněk (LCH) se odvíjí od rozsahu nemoci. Pro
lokalizované formy nemoci je stále základní léčbou chirurgický zákrok či ložisková aplikace …
lokalizované formy nemoci je stále základní léčbou chirurgický zákrok či ložisková aplikace …